Literature DB >> 8921393

Analysis of three deletion breakpoints in Xp21.1 and the further localization of RP3.

J Brown1, K L Dry, A J Edgar, F E Pryde, L J Hardwick, M A Aldred, D H Lester, S Boyle, J Kaplan, J L Dufier, M F Ho, A M Monaco, M A Musarella, A F Wright.   

Abstract

The gene responsible for X-linked retinitis pigmentosa (xlRP) in Xp21.1 (RP3) was initially localized by deletion analysis to within a 150- to 170-kb region between the CYBB locus and the proximal deletion junction (BBJPROX) from a patient, BB, who suffered from Duchenne muscular dystrophy (DMD), McLeod syndrome, chronic granulomatous disease (CGD), and xlRP. This gene has recently been isolated and was found to be located outside and 400 kb proximal to the BB deletion. Further analysis of BBJPROX has identified the breakpoint junction sequence, showing that it occurs within an Alu repetitive element on the proximal side but with no significant homology to the distal sequence in dystrophin intron 30. Analysis of an overlapping deletion in patient NF, who suffered from DMD, CGD, and McLeod syndrome, shows that this deletion is within 4 kb but extends centromeric to BBJPROX, consistent with the location of RP3 outside the BB deletion region. A sequence with strong homology to a THE-1 transposon-like element was identified 7-13 kb from the proximal BB and NF breakpoints. These elements have been implicated in several highly unstable genomic regions. A third overlapping deletion, in a patient, SB, who suffered from CGD, McLeod syndrome, and xlRP, has here been shown to extend 380 kb proximal to the NF breakpoint, consistent with the finding that RP3 lies outside the BB deletion. This deletion has now been shown to disrupt the RP3 (RPGR) gene. The reason for the retinitis pigmentosa phenotype in patient BB remains unclear, but the most likely explanations include a long-range chromosomal position effect, a small secondary rearrangement, and the presence of a coincident autosomal form of retinitis pigmentosa.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8921393     DOI: 10.1006/geno.1996.0543

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  5 in total

1.  Complex management of a patient with a contiguous Xp11.4 gene deletion involving ornithine transcarbamylase: a role for detailed molecular analysis in complex presentations of classical diseases.

Authors:  Matthew A Deardorff; Himabindu Gaddipati; Paige Kaplan; Pedro A Sanchez-Lara; Neal Sondheimer; Nancy B Spinner; Hakon Hakonarson; Can Ficicioglu; Jaya Ganesh; Thomas Markello; Brett Loechelt; Dina J Zand; Marc Yudkoff; Uta Lichter-Konecki
Journal:  Mol Genet Metab       Date:  2008-06-03       Impact factor: 4.797

Review 2.  Brain, blood, and iron: perspectives on the roles of erythrocytes and iron in neurodegeneration.

Authors:  Rainer Prohaska; Ody C M Sibon; Dobrila D Rudnicki; Adrian Danek; Susan J Hayflick; Esther M Verhaag; Jan J Vonk; Russell L Margolis; Ruth H Walker
Journal:  Neurobiol Dis       Date:  2012-03-09       Impact factor: 5.996

3.  Chronic granulomatous disease: a review of the infectious and inflammatory complications.

Authors:  Eunkyung Song; Gayatri Bala Jaishankar; Hana Saleh; Warit Jithpratuck; Ryan Sahni; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2011-05-31

4.  Chronic granulomatous disease, the McLeod phenotype and the contiguous gene deletion syndrome-a review.

Authors:  Casey E Watkins; John Litchfield; Eunkyung Song; Gayatri B Jaishankar; Niva Misra; Nikhil Holla; Michelle Duffourc; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2011-11-23

5.  Mechanism of Deletion Removing All Dystrophin Exons in a Canine Model for DMD Implicates Concerted Evolution of X Chromosome Pseudogenes.

Authors:  D Jake VanBelzen; Alock S Malik; Paula S Henthorn; Joe N Kornegay; Hansell H Stedman
Journal:  Mol Ther Methods Clin Dev       Date:  2016-12-24       Impact factor: 6.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.